Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle
Authors:
- Michael J HickeyMHMichael J Hickey
- Diana A LeporeDLDiana A Lepore
- Kenneth R KnightKKKenneth R Knight
- Wayne A MorrisonWMWayne A Morrison
- Alastair G StewartAlastair G Stewart
- 1 July 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 424 (1) , 59-67
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Ischaemia-reperfusion injuryBritish Journal of Surgery, 1994
- Does granulocyte depletion protect against ischaemic muscle necrosis?Scandinavian Journal of Clinical and Laboratory Investigation, 1994
- Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in ratsLife Sciences, 1994
- A Clinically Relevant Small-Animal Model of Skeletal Muscle Ischemia-Reperfusion InjuryJournal of Investigative Surgery, 1994
- The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusionCardiovascular Research, 1993
- Transient forebrain ischemia alters acutely endothelin receptor density and immunoreactivity in gerbil brainLife Sciences, 1993
- Reperfusion injury: A role for neutrophilsHepatology, 1991
- Endothelin acts in feline and canine cerebral arteries from the adventitial side.Stroke, 1989
- Pharmacological Effect of Endothelin, an Endothelium-derived Vasoconstrictive Peptide, on Canine Basilar ArteriesNeurologia medico-chirurgica, 1989
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985